{"id":929649,"date":"2026-01-22T07:03:18","date_gmt":"2026-01-22T12:03:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/"},"modified":"2026-01-22T07:03:18","modified_gmt":"2026-01-22T12:03:18","slug":"united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/","title":{"rendered":"United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors"},"content":{"rendered":"<p>        <!--body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p><b>United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors<\/b><\/p>\n<p>SILVER SPRING, Md. &amp; DURHAM, N.C.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nUnited Therapeutics Corporation (Nasdaq: <b>UTHR<\/b>), a public benefit corporation, announced today that the company\u2019s Board of Directors appointed <b>Kevin J. Tracey, M.D., <\/b>to its Board on January 21, 2026.<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20260122174254\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260122174254\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260122174254\/en\/2698300\/4\/Headshot.jpg\" alt=\"Kevin Tracey was recently elected to United Therapeutics' Board of Directors.\" \/><\/p>\n<p style=\"font-size:85%\">Kevin Tracey was recently elected to United Therapeutics&#8217; Board of Directors.<\/p>\n<\/div>\n<p>\nDr. Tracey is President, CEO, and the Karches Family Distinguished Chair in Medical Research at The Feinstein Institutes for Medical Research. He is a Professor of Molecular Medicine and Neurosurgery at the Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell and Executive Vice President, Research, at Northwell Health. A leader in the scientific fields of inflammation and bioelectronic medicine, Dr. Tracey\u2019s contributions include discovery and molecular mapping of neural circuits controlling immunity, as well as identifying the therapeutic action of monoclonal anti-TNF antibodies. Dr. Tracey is the co-founder of several biotechnology companies, including SetPoint Medical, the industry leader in bioelectronic medicine.<\/p>\n<p>\n\u201cDr. Tracey brings to our Board a rare combination of scientific leadership, entrepreneurial experience, and groundbreaking research expertise. With his extensive executive leadership at major research institutions, pioneering discoveries in inflammation and bioelectronic medicine, entrepreneurial track record, and numerous patents and influential publications, Dr. Tracey is a visionary researcher who can successfully translate science into commercial applications. I believe his strategic vision and deep scientific expertise will provide invaluable guidance to United Therapeutics&#8217; mission and growth,\u201d said <b>Martine Rothblatt, Ph.D.<\/b>, Chairperson and Chief Executive Officer of United Therapeutics.<\/p>\n<p>\n\u201cI am delighted to join United Therapeutics\u2019 Board of Directors as the company advances its impressive therapeutic pipeline for rare pulmonary diseases and its groundbreaking organ manufacturing development programs. I look forward to supporting United Therapeutics in its patient-driven mission to transform the treatment of rare disease and expand the availability of transplantable organs,\u201d said Dr. Tracey.<\/p>\n<p>\n\u201cDr. Tracey is the latest stellar addition to our Board, continuing our strong track record of board refreshment,\u201d said <b>Christopher Causey<\/b>, Chairperson of the Nominating and Governance Committee of United Therapeutics\u2019 Board of Directors. \u201cDr. Tracey brings invaluable scientific insight and operational healthcare experience to our Board.\u201d<\/p>\n<p><b>United Therapeutics: Enabling Inspiration<\/b><\/p>\n<p>\nAt United Therapeutics, our vision and mission are one. We use our enthusiasm, creativity, and persistence to innovate for the unmet medical needs of our patients and to benefit our other stakeholders. We are bold and unconventional. We have fun, we do good. We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation (<b>PBC<\/b>). Our public benefit purpose is to provide a brighter future for patients through (a) the development of novel pharmaceutical therapies; and (b) technologies that expand the availability of transplantable organs.<\/p>\n<p>\nYou can learn more about what it means to be a PBC here: <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Funither.com%2Fpbc&amp;esheet=54401349&amp;newsitemid=20260122174254&amp;lan=en-US&amp;anchor=unither.com%2Fpbc&amp;index=1&amp;md5=a2737601e245d358f70779b03b4ea735\">unither.com\/pbc<\/a>.<\/p>\n<p><b>Forward-Looking Statements<\/b><\/p>\n<p>\nStatements included in this press release that are not historical in nature are \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, among others, Dr. Tracey\u2019s expected contributions to the Board of Directors; the company\u2019s pipeline; and our efforts to innovate for the unmet medical needs of our patients, to benefit our other stakeholders, and to pursue our public benefit purpose of developing novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. These forward-looking statements are subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, that could cause actual results to differ materially from anticipated results. Consequently, such forward-looking statements are qualified by the cautionary statements, cautionary language, and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. We claim the protection of the safe harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. We are providing this information as of January 22, 2026, and assume no obligation to update or revise the information contained in this press release whether because of new information, future events or any other reason.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260122174254r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260122174254\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260122174254\/en\/<\/a><\/span><\/p>\n<p><b>For Further Information Contact:<br \/>\n<br \/><\/b>Investor Inquiries<br \/>\n<br \/><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.unither.com%2Fcontact-ir&amp;esheet=54401349&amp;newsitemid=20260122174254&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.unither.com%2Fcontact-ir&amp;index=2&amp;md5=8db61bbeca45d4c8c288c9812bc3b599\">https:\/\/ir.unither.com\/contact-ir<\/a><\/p>\n<p>\nMedia Inquiries<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:communications@unither.com\">communications@unither.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> North Carolina Maryland United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health Other Health<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20260122174254\/en\/2698300\/3\/Headshot.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">Kevin Tracey was recently elected to United Therapeutics&#8217; Board of Directors.<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors SILVER SPRING, Md. &amp; DURHAM, N.C.&#8211;(BUSINESS WIRE)&#8211; United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the company\u2019s Board of Directors appointed Kevin J. Tracey, M.D., to its Board on January 21, 2026. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260122174254\/en\/ Kevin Tracey was recently elected to United Therapeutics&#8217; Board of Directors. Dr. Tracey is President, CEO, and the Karches Family Distinguished Chair in Medical Research at The Feinstein Institutes for Medical Research. He is a Professor of Molecular Medicine and Neurosurgery at the Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell and Executive Vice President, Research, at Northwell &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-929649","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors SILVER SPRING, Md. &amp; DURHAM, N.C.&#8211;(BUSINESS WIRE)&#8211; United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the company\u2019s Board of Directors appointed Kevin J. Tracey, M.D., to its Board on January 21, 2026. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260122174254\/en\/ Kevin Tracey was recently elected to United Therapeutics&#8217; Board of Directors. Dr. Tracey is President, CEO, and the Karches Family Distinguished Chair in Medical Research at The Feinstein Institutes for Medical Research. He is a Professor of Molecular Medicine and Neurosurgery at the Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell and Executive Vice President, Research, at Northwell &hellip; Continue reading &quot;United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-22T12:03:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260122174254\/en\/2698300\/4\/Headshot.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors\",\"datePublished\":\"2026-01-22T12:03:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\\\/\"},\"wordCount\":788,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260122174254\\\/en\\\/2698300\\\/4\\\/Headshot.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\\\/\",\"name\":\"United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260122174254\\\/en\\\/2698300\\\/4\\\/Headshot.jpg\",\"datePublished\":\"2026-01-22T12:03:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260122174254\\\/en\\\/2698300\\\/4\\\/Headshot.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260122174254\\\/en\\\/2698300\\\/4\\\/Headshot.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors - Market Newsdesk","og_description":"United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors SILVER SPRING, Md. &amp; DURHAM, N.C.&#8211;(BUSINESS WIRE)&#8211; United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the company\u2019s Board of Directors appointed Kevin J. Tracey, M.D., to its Board on January 21, 2026. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20260122174254\/en\/ Kevin Tracey was recently elected to United Therapeutics&#8217; Board of Directors. Dr. Tracey is President, CEO, and the Karches Family Distinguished Chair in Medical Research at The Feinstein Institutes for Medical Research. He is a Professor of Molecular Medicine and Neurosurgery at the Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell and Executive Vice President, Research, at Northwell &hellip; Continue reading \"United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-22T12:03:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260122174254\/en\/2698300\/4\/Headshot.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors","datePublished":"2026-01-22T12:03:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/"},"wordCount":788,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260122174254\/en\/2698300\/4\/Headshot.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/","name":"United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260122174254\/en\/2698300\/4\/Headshot.jpg","datePublished":"2026-01-22T12:03:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260122174254\/en\/2698300\/4\/Headshot.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260122174254\/en\/2698300\/4\/Headshot.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/united-therapeutics-corporation-announces-appointment-of-kevin-j-tracey-to-its-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/929649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=929649"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/929649\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=929649"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=929649"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=929649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}